The Cromer blood group system: an update.

Area of Science:

• Immunohematology
• Molecular Biology
• Infectious Disease Research

Background:

• The Cromer (CROM) blood group system, also known as ISBT021, is defined by antigens on the CD55 (Decay Accelerating Factor) molecule.
• CD55 (DAF) plays a significant role in regulating complement activation and has been identified as a receptor for the malaria parasite, Plasmodium falciparum.
• Previous reviews have established the foundational knowledge of the Cromer system, but ongoing research continues to uncover new complexities.

Purpose of the Study:

• To provide an updated comprehensive review of the Cromer blood group system (ISBT021).
• To detail newly identified antigens and variants within the Cromer system.
• To elucidate the molecular bases underlying the null phenotype in this blood group system.

Main Methods:

• Literature review and synthesis of recent findings in immunohematology and molecular genetics.
• Analysis of data pertaining to CD55 (DAF) expression and its association with blood group phenotypes.
• Integration of information on the role of CD55 in Plasmodium falciparum infection.

Main Results:

• The Cromer blood group system has expanded with the identification of additional variants and novel antigens.
• New molecular underpinnings for the null phenotype within the Cromer system have been elucidated.
• The established role of CD55 (DAF) as a receptor for Plasmodium falciparum is reinforced, with its broader implications in health and disease highlighted.

Conclusions:

• The Cromer blood group system is dynamic, with continuous discoveries of new antigens and molecular variations.
• Understanding these updates is critical for transfusion medicine and for comprehending host-pathogen interactions, particularly with Plasmodium falciparum.
• The expanding role of CD55 (DAF) in various physiological and pathological processes warrants further investigation.